Abstract:Key PointsMost heat-shock proteins (HSPs) are constitutively expressed molecular chaperones that guide the normal folding, intracellular disposition and proteolytic turnover of many of the key regulators of cell growth and survival. Their levels of intracellular expression increase in response to protein-denaturing stressors, such as temperature change, as an evolutionarily conserved response to restore the normal protein-folding environment and to enhance cell survival.The essential chaperoning functions of HSPs are subverted during oncogenesis to make malignant transformation possible and to facilitate rapid somatic evolution.Functioning as biochemical buffers for the numerous genetic lesions that are present within tumours, chaperones, especially HSP90, allow mutant proteins to retain or even gain function while permitting cancer cells to tolerate the imbalanced signalling that such oncoproteins create.Highly specific inhibitors of HSP90 have been identified that redirect its chaperoning activity and decrease cellular levels of the many cancer-related client proteins that depend on it for their function.The use of HSP90 inhibitors has proven invaluable at a basic level in probing the complex cellular functions of this chaperone.The modulation of client protein levels has been demonstrated in animal models and cancer patients following systemically well-tolerated exposure to the HSP90 inhibitor 17AAG, which is the first in its class.Work is ongoing to identify and develop new HSP90 inhibitors with improved pharmacological properties.The best way to exploit the novel mechanism of action of HSP90 inhibitors for anticancer therapy remains to be defined, but probably involves combination with conventional cytotoxic drugs or other molecularly targeted agents.

Chaperoning checkpoint kinase 1 (Chk1), an Hsp90 client, with purified chaperones

Implications for Chk1 Regulation: the 1.7 Å Crystal Structure of Human Cell Cycle Checkpoint Kinase Chk1

The Regulatory Mechanism of A Client Kinase Controlling Its Own Release from Hsp90 Chaperone Machinery Through Phosphorylation

Conformational processing of oncogenic v-Src kinase by the molecular chaperone Hsp90

Characterization of the CHK1 allosteric inhibitor binding site.

The chaperoning activity of hsp110. Identification of functional domains by use of targeted deletions

Structural Basis for the Inhibition of HSP70 and DnaK Chaperones by Small-Molecule Targeting of a C-Terminal Allosteric Pocket

Structural basis for the dynamic chaperoning of disordered clients by Hsp90

Chk1 Regulates the S Phase Checkpoint by Coupling the Physiological Turnover and Ionizing Radiation-Induced Accelerated Proteolysis of Cdc25A.

Establishing Order through Disorder by the Hsp90 Molecular Chaperone

Mutational analysis of GSK3β protein kinase together with kinome-wide binding and stability studies suggest context-dependent recognition of kinases by the chaperone HSP90.

Atomic structure of Hsp90-Cdc37-Cdk4 reveals that Hsp90 traps and stabilizes an unfolded kinase

Site‐selectively Phosphorylated Hsp90 C‐terminal Domain Variants Provide Access to Deciphering the Chaperone Code.

The co-chaperone p23 arrests the Hsp90 ATPase cycle to trap client proteins.

Conformational Dynamics of the Molecular Chaperone Hsp90 in Complexes with a Co-chaperone and Anticancer Drugs

Advances towards Understanding the Mechanism of Action of the Hsp90 Complex

The Hsp90 chaperone machinery: Conformational dynamics and regulation by co-chaperones

HSP90 and the chaperoning of cancer

Structure, Function, and Regulation of the Hsp90 Machinery

Cracking the chaperone code through the computational microscope

Substrate Transfer from the Chaperone Hsp70 to Hsp90